(+)-Catechin Attenuates Multiple Atherosclerosis-Associated Processes In Vitro, Modulates Disease-Associated Risk

Yee-Hung Chan1, Joe W E Moss1, Jessica O Williams1

  • 1Cardiff School of Biosciences, Cardiff University, Sir Martin Evans Building, Museum Avenue, Cardiff, CF10 3AX, UK.

Insights

(+)-Catechin, a compound found in green tea, shows promise in preventing heart disease. This study reveals its protective effects against atherosclerosis by reducing inflammation and improving key cardiovascular risk factors.

Area of Science:

  • Cardiovascular Science
  • Nutritional Biochemistry
  • Molecular Biology

Background:

  • Coronary heart disease (CHD) remains a leading cause of mortality worldwide.
  • (+)-Catechin intake is inversely associated with CHD risk in large human studies.
  • The precise mechanisms by which (+)-catechin exerts its cardioprotective effects are not fully understood.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying the cardioprotective effects of (+)-catechin.
  • To evaluate the impact of (+)-catechin on atherosclerosis and related risk factors in cellular and animal models.

Main Methods:

  • In vitro studies using human macrophages, endothelial cells, and vascular smooth muscle cells.
  • In vivo studies using C57BL/6J mice and LDL receptor-deficient mice fed a high-fat diet.
  • Analysis of gene expression, cellular proliferation, migration, and inflammatory markers.

Main Results:

  • (+)-Catechin attenuated reactive oxygen species production, monocytic migration, and pro-atherogenic gene expression in human cells.
  • In mice, (+)-catechin reduced plasma triacylglycerol, inflammatory cytokines (IL-1β, IL-2), and altered bone marrow cell populations.
  • In LDL receptor-deficient mice, (+)-catechin significantly reduced atherosclerotic plaque burden, inflammation, and enhanced plaque stability.

Conclusions:

  • (+)-Catechin demonstrates significant cardio-protective actions through multiple molecular pathways.
  • The findings provide detailed insights into the anti-atherogenic properties of (+)-catechin.
  • This study supports further clinical investigation of (+)-catechin for cardiovascular disease prevention.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
18
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
38
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
18
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
26
Inflammation01:38

Inflammation

Overview
54.1K